AFFINITY MEDICAL SERVICES LTD
Company number 07672576 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Affinity Medical Services Ltd
1. Financial Health Score: D+
Explanation: The company exhibits multiple symptoms of financial distress, most critically a severe liquidity crisis evidenced by an overdrawn bank account and a current ratio of near-zero. While net assets remain positive (£133,201) and the business continues to operate, the dramatic deterioration in key metrics over the past two years — including a near-ninefold increase in bank borrowings and a shift from healthy cash reserves to an overdrawn position — signals a patient in acute need of intervention. The trajectory is concerning, though not yet terminal.
2. Key Vital Signs
Liquidity (Critical Condition 🔴)
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Current Assets | £17,460 | £21,474 | -18.7% |
| Current Liabilities | £357,642 | £159,335 | +124.4% |
| Current Ratio | 0.049 | 0.135 | Deteriorated |
| Net Current Assets | (£340,182) | (£137,861) | Worsened by £202,321 |
| Cash at Bank | (£5,523) | £21,474 | Overdrawn |
Interpretation: This is the financial equivalent of a patient whose blood pressure has crashed. A current ratio below 1.0 indicates insufficient short-term assets to cover near-term obligations; a ratio of 0.049 is critically ill. The company has barely 5p in current assets for every £1 owed within the year. The bank account has shifted from a £21,474 credit balance to a £5,523 overdraft — the business is now living on borrowed time.
Solvency & Leverage (Serious Condition 🔴)
| Metric | 2024 | 2023 |
|---|---|---|
| Total Assets | £498,942 | £329,926 |
| Total Liabilities | £365,741 | £162,875 |
| Net Assets | £133,201 | £167,051 |
| Debt-to-Equity Ratio | 2.75 | 0.97 |
Interpretation: The debt-to-equity ratio has nearly tripled from 0.97 to 2.75 in a single year. For every £1 of shareholder equity, the company now owes £2.75 to creditors. This is a dramatic and dangerous increase in financial leverage — like a patient whose cholesterol has suddenly spiked.
Profitability (Deteriorating 🟡→🔴)
| Metric | 2024 | 2023 |
|---|---|---|
| P&L Reserve | £133,101 | £166,951 |
| Implied Profit/(Loss) | (£33,850) | — |
Interpretation: The retained earnings reserve has declined by £33,850, indicating the company generated a loss during FY2024. This follows a pattern of declining net assets from the peak of £201,697 in 2022 — a cumulative erosion of £68,496 over two years. The business is haemorrhaging value.
Asset Composition (Structural Concern 🟡)
| Asset Category | 2024 | 2023 |
|---|---|---|
| Tangible Fixed Assets | £107,882 | £134,852 |
| Investments | £373,600 | £173,600 |
| Current Assets | £17,460 | £21,474 |
Interpretation: The company has become asset-heavy and liquidity-light. Investments increased by £200,000 (funded primarily by bank borrowing), while tangible assets are depreciating and current assets are negligible. This is akin to a patient with significant property but no cash to pay for daily medication.
Debt Structure (Alarming 🔴)
| Creditor Type | 2024 | 2023 | Change |
|---|---|---|---|
| Bank Loans (due < 1 year) | £289,536 | £32,500 | +791% |
| Taxation & Social Security | £67,983 | £72,360 | -6.1% |
| Other Creditors (due < 1 year) | £54,475 | £0 | New |
| Other Creditors (due > 1 year) | £8,099 | £3,540 | +129% |
Interpretation: The near-ninefold increase in short-term bank borrowing is the most alarming symptom. The company has taken on approximately £257,000 in additional bank debt due within one year, while simultaneously adding £200,000 in investments. This suggests the business may be leveraging short-term debt to fund long-term investments — a classic mismatch that creates significant rollover risk.
3. Diagnosis
Primary Condition: Acute Liquidity Crisis with Leveraged Investment Strategy
The financial data reveals a business that has undergone a dramatic and risky transformation in FY2024. The core diagnosis is threefold:
(a) Severe Working Capital Deficit
With net current liabilities of £340,182, the company has a structural shortfall between what it owes in the short term and what it can access. The overdrawn bank account confirms the business cannot meet its obligations from operating cash flow alone. This is the financial equivalent of respiratory distress — the organisation is struggling to breathe day-to-day.
(b) Aggressive Debt-Funded Investment
The £200,000 addition to investments, funded predominantly by a £257,036 increase in short-term bank borrowings, represents a significant strategic bet. While investment in growth can be healthy, funding long-term assets with short-term debt creates a maturity mismatch — the investments won't generate returns before the debt demands repayment. This is like taking out a payday loan to fund a pension contribution.
(c) Declining Operational Performance
The reduction in employees from 12 to 9, combined with the loss indicated by declining retained earnings, suggests the core medical practice may be contracting. The appearance of £22,983 in debtors (previously nil) could indicate delayed payment collection or a change in billing practices.
Historical Context
The company has a history of financial volatility — negative net assets in 2015 and 2018, followed by significant recovery. However, the current deterioration is more concerning because it involves a structural shift in the balance sheet (massive bank debt) rather than a simple trading downturn.
4. Recommendations
Immediate (Within 30 Days) — Stabilise the Patient
-
Emergency Cash Flow Management: The overdrawn bank account requires immediate attention. Negotiate an extended overdraft facility or arrange a short-term repayment holiday with the lender. Prepare a 13-week cash flow forecast to understand exactly when and where cash shortfalls will occur.
-
Review Bank Loan Terms: With £289,536 due within one year, clarify whether these are demand loans or have fixed repayment schedules. If demand loans, the company is at extreme risk of the bank calling in the debt. Consider refinancing short-term debt onto longer-term facilities.
-
Debtor Collection: The £22,983 in debtors should be chased immediately. For a medical practice, this likely represents NHS or private patient receivables — ensure billing is timely and collection procedures are active.
Short-Term (1-6 Months) — Begin Treatment
-
Investment Liquidity Review: The £373,600 in investments is now the company's largest asset. Critically assess whether these investments can be partially liquidated to reduce bank debt. If they are in group companies or related parties, understand the exit options and realistic valuations.
-
Debt Restructuring: Aim to convert at least £200,000 of the short-term bank debt into medium-to-long-term facilities. The current maturity mismatch is unsustainable — investments typically don't generate liquidity within 12 months.
-
Cost Reduction Programme: With a declining workforce and apparent trading losses, conduct a thorough review of overhead costs. Identify non-essential expenditure and renegotiate supplier terms.
Medium-Term (6-18 Months) — Recovery and Rehabilitation
-
Revenue Strategy Assessment: As a specialist medical practice, evaluate whether the reduction from 12 to 9 employees reflects a deliberate downsizing or a symptom of lost contracts. Develop a clear revenue growth plan with realistic timelines.
-
Director Loan Consideration: Given Mr Ahmed's 75%+ ownership and control, consider whether a director's loan or additional equity injection could reduce bank dependence and improve the balance sheet structure.
-
Quarterly Financial Health Checks: Implement quarterly management accounts with specific KPIs: current ratio target of 0.5 minimum, cash positivity, and debt-to-equity below 2.0. The company should not wait another full year before reviewing its position.
Ongoing Monitoring
- Early Warning System: Set up alerts for key metrics — if the bank overdraft exceeds £10,000, if current liabilities exceed £400,000, or if the P&L reserve drops below £100,000, these should trigger immediate management review.
Risk Assessment Summary
| Risk Factor | Severity | Likelihood | Impact |
|---|---|---|---|
| Bank calling in short-term debt | 🔴 Critical | Medium | Insolvency |
| Inability to meet payment obligations | 🔴 Critical | High | Trading disruption |
| Investment illiquidity | 🟡 High | Medium | Cash flow crisis |
| Continued trading losses | 🟡 High | Medium | Equity erosion |
| Regulatory concern (medical practice) | 🟢 Low | Low | Reputational |